Stocks in play: Oncolytics Biotech® Inc.

Today announced that Dr. Matt Coffey, President and Chief Executive Officer, will participate in the Novel Mechanisms with Important Readouts panel at Cantor Fitzgerald's The Future of Oncology Virtual Symposium, which is taking place April 3-5, in a virtual format. Oncolytics Biotech® Inc. shares T.ONC are trading up $0.03 at $1.72.

Read:

• International Lithium Buyers Looking to South America to Fill Supply Gaps

• Race to Secure Critical EV Battery Metals Ahead of Chinese Dominance Fully Underway

• Help is on the Way as Rising Alzheimer’s Cases Highlight Urgency for New Treatments

• FDA’s Wave of Fast Track Designations Pushing Momentum in Healthcare Sector in 2023

• Interest in Gold Miners Increases as Bank Fiasco Causes Market to Seek Safe Haven Assets